Abstract
Cyclooxygenase (COX) expression in the brain is associated with pro-inflammatory activities, which are instrumental in neurodegenerative processes such as Parkinsons disease (PD). It is discussed that drugs with the capacity to rescue dopaminergic neurons from microglia toxicity and neuroinflammatory processes may result in an amelioration of parkinsonian symptoms by delaying the onset or slowing progression. This article reviews the involvement of COX in neuroinflammation, specifically focussing at the role of selective COX-2 inhibition in neuroinflammation and neurodegeneration in Parkinsons disease.
Keywords: COX-2, Parkinson, neuroinflammation, microglia, neurodegeneration, neuroprotection
Current Neuropharmacology
Title: Cyclooxygenase and Neuroinflammation in Parkinsons Disease Neurodegeneration
Volume: 8 Issue: 1
Author(s): Anna L. Bartels and Klaus L. Leenders
Affiliation:
Keywords: COX-2, Parkinson, neuroinflammation, microglia, neurodegeneration, neuroprotection
Abstract: Cyclooxygenase (COX) expression in the brain is associated with pro-inflammatory activities, which are instrumental in neurodegenerative processes such as Parkinsons disease (PD). It is discussed that drugs with the capacity to rescue dopaminergic neurons from microglia toxicity and neuroinflammatory processes may result in an amelioration of parkinsonian symptoms by delaying the onset or slowing progression. This article reviews the involvement of COX in neuroinflammation, specifically focussing at the role of selective COX-2 inhibition in neuroinflammation and neurodegeneration in Parkinsons disease.
Export Options
About this article
Cite this article as:
Bartels L. Anna and Leenders L. Klaus, Cyclooxygenase and Neuroinflammation in Parkinsons Disease Neurodegeneration, Current Neuropharmacology 2010; 8 (1) . https://dx.doi.org/10.2174/157015910790909485
DOI https://dx.doi.org/10.2174/157015910790909485 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Pathophysiology of Atherosclerosis: The Role of Inflammation
Current Pharmaceutical Design Novel Biomarkers Assessing Endothelial Dysfunction: Role of microRNAs
Current Topics in Medicinal Chemistry The Fixed Combination Efficacy Assessment in Patients with Secondary Neovascular Glaucoma and Diabetes Mellitus
Current Diabetes Reviews The Effects of Obesity on the Cerebral Vasculature
Current Vascular Pharmacology Cytotoxicity and Toxicity to Animals and Humans of Ribosome-Inactivating Proteins
Mini-Reviews in Medicinal Chemistry Protective Effects of Diuretics Against the Development of Cardiovascular Disease in Patients with Chronic Kidney Disease: A Systematic Review
Cardiovascular & Hematological Agents in Medicinal Chemistry Microcirculation of the Diabetic Foot
Current Pharmaceutical Design ATP-Sensitive K+ Channels: Current and Putative Target for the Prevention and Treatment of Cardiovascular Diseases
Vascular Disease Prevention (Discontinued) Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment - A Phase II Controlled Study
Current Drug Delivery “Stress” is 80 Years Old: From Hans Selye Original Paper in 1936 to Recent Advances in GI Ulceration
Current Pharmaceutical Design Conductance and Resistance Vessels in Arterial Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Human Papilloma Virus Vaccine Associated Uveitis
Current Drug Safety Mesenchymal Stem Cells in Renal Ischemia-Reperfusion Injury: Biological and Therapeutic Perspectives
Current Stem Cell Research & Therapy Static Cerebral Blood Flow Autoregulation in Humans
Current Hypertension Reviews Recent Patents on Ocular Drug Delivery Systems
Recent Patents on Drug Delivery & Formulation Cardiovascular Effects of Phosphodiesterase 5 Inhibitors
Current Pharmaceutical Design A Current Update on the Use of Alpha Lipoic Acid in the Management of Type 2 Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets Neuroinflammation and Immunity: A New Pharmacological Target in Depression
CNS & Neurological Disorders - Drug Targets Metabolic and Cardiovascular Ageing Indices in Relation to Glycated Haemoglobin in Healthy and Diabetic Subjects
Current Aging Science Controversies in Glaucoma: Current Medical Treatment and Drug Development
Current Pharmaceutical Design